Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

(2013) Regina Kunz et al.   ANNALS OF INTERNAL MEDICINE

Effect of Telmisartan on Renal Outcomes

(2013) Johannes F.E. Mann   ANNALS OF INTERNAL MEDICINE

Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension

(2010) Maurizio Galderisi et al.   JOURNAL OF HYPERTENSION

Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

(2009) David S. Wald et al.   AMERICAN JOURNAL OF MEDICINE

Baseline Values but Not Treatment-Induced Changes in Carotid Intima-Media Thickness Predict Incident Cardiovascular Events in Treated Hypertensive Patients

(2009) Alberto Zanchetti et al.   CIRCULATION

Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy

(2009) Scott D. Solomon et al.   CIRCULATION

Aortic Pulse Wave Velocity Predicts Cardiovascular Mortality in Middle-Aged and Elderly Japanese Men

(2009) Noriko Inoue et al.   CIRCULATION JOURNAL

Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension

(2009) Thomas W. Littlejohn et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial

(2009) J. W. J. Beulens et al.   DIABETOLOGIA

Olmesartan Medoxomil/Amlodipine

(2009) Mark Sanford et al.   DRUGS

Prevention of risk factors: beta-blockade and hypertension

(2009) G. Mancia   EUROPEAN HEART JOURNAL SUPPLEMENTS

Single-pill combination of amlodipine and valsartan in the management of hypertension

(2009) John M Flack et al.   EXPERT OPINION ON PHARMACOTHERAPY

Large and Small Artery Cross-Talk and Recent Morbidity-Mortality Trials in Hypertension

(2009) Stéphane Laurent et al.   HYPERTENSION

Principal Results of the Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)

(2009) JATOS Study Group   HYPERTENSION RESEARCH

Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients

(2009) Toshio Ogihara et al.   HYPERTENSION RESEARCH

Beta-blockade should not be among several choices for initial therapy of hypertension

(2009) Lionel H Opie   JOURNAL OF HYPERTENSION

Choice of antihypertensive drugs in the European Society of Hypertension–European Society of Cardiology guidelines: specific indications rather than ranking for general usage

(2009) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study

(2009) Zhibin Li et al.   JOURNAL OF HYPERTENSION

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

(2009) Roland E Schmieder et al.   JOURNAL OF HYPERTENSION

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League

(2009) Stephan Lüders et al.   JOURNAL OF HYPERTENSION

A comparison of atenolol and nebivolol in isolated systolic hypertension

(2009) Zahid Dhakam et al.   JOURNAL OF HYPERTENSION

Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy

(2009) Giovanni Corrao et al.   JOURNAL OF HYPERTENSION

Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population

(2009) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients

(2009) M Lorenza Muiesan et al.   JOURNAL OF HYPERTENSION

Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175 634 patients

(2009) Pierluigi Costanzo et al.   JOURNAL OF HYPERTENSION

Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension

(2009) Peter S Sever et al.   JOURNAL OF HYPERTENSION

Cardio–renal organ damage and cardiovascular outcomes in hypertension

(2009) Cesare Cuspidi   JOURNAL OF HYPERTENSION

Target organ damage: how to detect it and how to treat it?

(2009) Bernard Waeber et al.   JOURNAL OF HYPERTENSION

Clinical significance of left ventricular hypertrophy and changes in left ventricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan trial

(2009) Shinji Yasuno et al.   JOURNAL OF HYPERTENSION

Management of antihypertensive drugs in three European countries

(2009) Federica Nicotra et al.   JOURNAL OF HYPERTENSION

Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?

(2009) Alberto Zanchetti   JOURNAL OF HYPERTENSION

Antihypertensive treatment and risk of cardiovascular complications: is the cure worse than the disease?

(2009) Hans Ibsen   JOURNAL OF HYPERTENSION

Latin American guidelines on hypertension*

(2009) Ramiro A Sanchez et al.   JOURNAL OF HYPERTENSION

Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials

(2009) Massimo Volpe et al.   JOURNAL OF HYPERTENSION

Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?

(2009) Kang-Ling Wang et al.   JOURNAL OF HYPERTENSION

Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study

(2009) Kei Asayama et al.   JOURNAL OF HYPERTENSION

Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients

(2009) Léon H Henskens et al.   JOURNAL OF HYPERTENSION

Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension

(2009) Alberto Zanchetti et al.   JOURNAL OF HYPERTENSION

The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy

(2009) Paolo Verdecchia et al.   JOURNAL OF HYPERTENSION

Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study

(2009) Costas Tsioufis et al.   JOURNAL OF HYPERTENSION

Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?

(2009) Thomas Sehestedt et al.   JOURNAL OF HYPERTENSION

When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal

(2009) Alberto Zanchetti et al.   JOURNAL OF HYPERTENSION

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

(2009) Peter Sleight et al.   JOURNAL OF HYPERTENSION

Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

(2009) T. Ninomiya et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes

(2009) B. E. de Galan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Add-On Benefits of Amlodipine and Thiazide in Nondiabetic Chronic Kidney Disease Stage 1/2 Patients Treated with Valsartan

(2009) Yuki Kaneshiro et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial

(2009) Paolo Verdecchia et al.   LANCET

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

(2009)   LANCET

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

(2009) Hiddo J Lambers Heerspink et al.   LANCET

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

(2009) Kausik K Ray et al.   LANCET

Valsartan for Prevention of Recurrent Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Vascular Structure and Function Is Correlated to Cognitive Performance and White Matter Hyperintensities in Older Hypertensive Patients With Subjective Memory Complaints

(2009) Anna Kearney-Schwartz et al.   STROKE

Left Ventricular Hypertrophy and Cardiovascular Mortality by Race and Ethnicity

(2008) Edward P. Havranek et al.   AMERICAN JOURNAL OF MEDICINE

Definition of Kidney Dysfunction as a Cardiovascular Risk FactorUse of Urinary Albumin Excretion and Estimated Glomerular Filtration Rate

(2008) Massimo Cirillo   ARCHIVES OF INTERNAL MEDICINE

Thiazide-Type Diuretics and β-Adrenergic Blockers as First-Line Drug Treatments for Hypertension

(2008) Jeffrey A. Cutler et al.   CIRCULATION

Risk/Benefit Assessment of β-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension

(2008) Franz H. Messerli et al.   CIRCULATION

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials

(2008) F. Turnbull et al.   EUROPEAN HEART JOURNAL

Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study)

(2008) E. Gerdts et al.   European Journal of Echocardiography

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡

(2008) Kenneth Dickstein et al.   EUROPEAN JOURNAL OF HEART FAILURE

Pulsatile but Not Steady Component of Blood Pressure Predicts Cardiovascular Events in Coronary Patients

(2008) Piotr Jankowski et al.   HYPERTENSION

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial

(2008) Hisao Ogawa   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality

(2008)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sexual dysfunction: the ‘prima ballerina’ of hypertension-related quality-of-life complications

(2008) Athanasios Manolis et al.   JOURNAL OF HYPERTENSION

Is prehypertension an independent predictor of target organ changes in young-to-middle-aged persons of African descent?

(2008) Gavin R Norton et al.   JOURNAL OF HYPERTENSION

Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis

(2008) Gianpaolo Reboldi et al.   JOURNAL OF HYPERTENSION

Relation of Beta-Blocker–Induced Heart Rate Lowering and Cardioprotection in Hypertension

(2008) Sripal Bangalore et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Resistant Hypertension

(2008) Pantelis A. Sarafidis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors

(2008) Ronald D. Smith et al.   Journal of the American Society of Hypertension

The COOPERATE trial: a letter of concern

(2008) Regina Kunz et al.   LANCET

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

(2008) Nish Chaturvedi et al.   LANCET

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

(2008) Ruth Peters et al.   LANCET NEUROLOGY

Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial

(2008) John F Potter et al.   LANCET NEUROLOGY

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

(2008) Hans-Henrik Parving et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of Hypertension in Patients 80 Years of Age or Older

(2008) Nigel S. Beckett et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

(2008) Salim Yusuf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

(2008) Peter Gæde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

(2008) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

(2008) Kenneth Jamerson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

(2008) William Duckworth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aortic Diameter, Wall Stiffness, and Wave Reflection in Systolic Hypertension

(2007) Gary F. Mitchell et al.   HYPERTENSION

Management of Hypertension in Peripheral Arterial Disease

(2007) Mark L. De Buyzere et al.   PROGRESS IN CARDIOVASCULAR DISEASES